KeyCorp (NYSE:KEY) is interesting. With one quarter of integrated Key-First Niagara numbers to look at and a clear strategy to realize value from the acquisition, investors can now assess what might be possible for KEY.
The new KeyCorp is shaping up to be a bank with annual revenue of nearly $6bn and a starting cost base of $3.9bn, which gives us a cost/income efficiency ratio of 65%. Management is looking to take out around $400m of costs over the medium term. A push to deepen relationships in the First Niagara (NASDAQ:FNFG) business will add costs while the synergy programme is being executed, so the risks – and possibilities – concern the pickup in revenue that can be achieved. If we allow ourselves some optimism over the Trump economy for banks, the prospects for the success of KEY’s acquisition have recently improved with regard to the top line.
I would view a central scenario for Key to 2019 as follows:
stocks and bonds: Alexandria Real Estate Equities, Inc.(ARE)
Advisors’ Opinion:
- [By WWW.MONEYSHOW.COM]
Take Alexandria Real Estate Equities (ARE), for example. The company deals heavily in tech real estate in New York and San Francisco among other places.
stocks and bonds: The ExOne Company(XONE)
Advisors’ Opinion:
- [By Peter Graham]
A long term performance chart shows shares of Stratasys, Ltd along with other small cap 3D printing stocks like 3D Systems Corporation (NYSE: DDD), ExOne Co (NASDAQ: XONE)and Voxeljet AG (NYSE: VJET) all peaking a few years with the bubble bursting and all showing some signs of stabilization or even a bit of a recent uptick:
- [By Paul Ausick]
Short interest in The ExOne Co. (NASDAQ: XONE) rose by 1.6% to 2.38 million shares. About 22.1% of the company’s shareswere short. ExOne’s share price fell by nearly 13% in the two weeks. The stock’s 52-week range is $6.60 to $16.15, and shares closed at $11.11 on Friday, down about 0.7% for the day. Days to cover fell from 17 to 13.
- [By Peter Graham]
A long term performance chart shows 3D Systems Corporation outperformingother 3D printing stocks like small caps ExOne Co (NASDAQ: XONE), Stratasys, Ltd (NASDAQ: SSYS)and Voxeljet AG (NYSE: VJET) with all four peaking around the same time in 2013/2014 before crashing with some signs of stabilization over the past 1 1/2 years:
- [By Peter Graham]
A long term performance chart shows shares of Stratasys, Ltd along with other small cap 3D printing stocks like 3D Systems Corporation (NYSE: DDD), ExOne Co (NASDAQ: XONE)and Voxeljet AG (NYSE: VJET) all peaking a few years and all showing some signs of stabilization over the past year:
stocks and bonds: Lexicon Pharmaceuticals, Inc.(LXRX)
Advisors’ Opinion:
- [By Paul Ausick]
Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) dropped about 12.3% Wednesday to post a new 52-week low of $12.93 after closing at $14.74 on Tuesday. The stock’s 52-week high is $19.62. Volume of around 2.8 million was nearly 5 times the daily average. The company had no specific news.
stocks and bonds: Genomic Health, Inc.(GHDX)
Advisors’ Opinion:
- [By Brian Orelli]
Genomic Health (NASDAQ:GHDX) closed up 10.2% Tuesday following its announcement of solid fourth-quarter earnings after the bell Monday. The company’s 2017 guidance certainly didn’t hurt investors’ confidence either.
- [By Brian Orelli]
Genomic Health (NASDAQ:GHDX) swung to a profit in the fourth quarter on the back of solid revenue growth and expects to have another productive year in 2017 as the company continues to increase reimbursement for its genetic tests.
stocks and bonds: Intercept Pharmaceuticals, Inc.(ICPT)
Advisors’ Opinion:
- [By Paul Ausick]
Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) dropped more than 17% Friday to post a new 52-week low of $60.97 after closing Thursday at $73.70. The 52-week high is $172.75. Volume of more than 10 million shares traded was about 12 times the daily average. The FDA on Thursday issued a warning letter on the company’s liver disease treatment.
- [By Peter Graham]
Small cap liver biopharmaceutical stock Intercept Pharmaceuticals Inc (NASDAQ: ICPT) reportedQ2 2017 earnings before the market opened on Monday with both the top and bottom lines beating expectations plus the Companyreported that amid-stage clinical trial met its primary endpoint; but sharesended the day down13.26%. Intercept Pharmaceuticals recognized $30.4 million of net sales of Ocaliva for Q2 2017 versus $75k and a net loss of $86.6 million versus a net loss of $77.3 million. Ocaliva was approved by the U.S.FDA in May 2016 for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. As of June 30, 2017,the Companyhad cash, cash equivalents and investment securities available for sale of approximately $550.3 million versus$689.4 million as of December 31, 2016. The CEO commented:
stocks and bonds: Rockwell Automation, Inc.(ROK)
Advisors’ Opinion:
- [By Paul Ausick]
Blaming the unwillingness of its target even to discuss a buyout, Emerson Electric Co. (NYSE: EMR) on Tuesday announced that it has withdrawn its unsolicited offer to acquire Rockwell Automation Inc. (NYSE: ROK) for $225 a share in a deal valued at nearly $30 billion.
- [By Lisa Levin]
Breaking news
Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected profit for its first quarter on Wednesday.
Helmerich & Payne, Inc. (NYSE: HP) posted upbeat results for its fourth quarter.
NetApp Inc. (NASDAQ: NTAP) reported stronger-than-expected results for its second quarter and issued strong Q3 guidance.
Emerson Electric Co. (NYSE: EMR) proposed to acquire Rockwell Automation (NYSE: ROK) for $225 per share in cash and stock. - [By Lee Jackson]
These companies also reported insider selling last week: Aetna Inc. (NYSE: AET), Cullen/Frost Bankers Inc. (NYSE: CFR), Rockwell Automation Inc. (NYSE: ROK), Stamps.com (NASDAQ: STMP) and Western Alliance Bancorporation (NYSE: WAL).
- [By Ben Levisohn]
Bernstein’s Steven Winoker looks back at 2016 for the industrial stocks he covers–Ingersoll-Rand (IR), Rockwell Automation (ROK), Eaton (ETN), and General Electric (GE) among them–and contemplates what 2017 might hold:
